Patents by Inventor WILLIAM M. VAUGHAN

WILLIAM M. VAUGHAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11989009
    Abstract: Methods and systems to control stacked hexapod platforms for use as tools, which function with both high accuracy and high precision are provided. In some embodiments, the methods and systems include a convergence of modern control theory, and machine learning. Furthermore, some embodiments provide control algorithms to carry out autonomous in-space assembly operations using assemblers. Some embodiments provide methods and systems which combine long-reach low precision manipulators and smaller, high-precision assembler with interchangeable tools.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: May 21, 2024
    Assignee: United States of America as represented by the Administrator of NASA
    Inventors: James H. Neilan, II, Matthew K. Mahlin, John R. Cooper, Laura M. White, Benjamin N. Kelley, Matthew P Vaughan, Iok M. Wong, John W. Mulvaney, Erik E. Komendera, William D Chapin, Joshua N. Moser, Samantha H. G. Chapin
  • Patent number: 10058471
    Abstract: A system and method are provided for performing hyperbaric oxygen therapy treatment to stop a cascading effect of an inflammatory response to an injury. Hyperbaric oxygen therapy is performed during the inflammation to suppress the release of cytokines, most preferably, within 72 hours of sustaining the injury. Subject to evaluation of the patient, at least a second hyperbaric oxygen therapy treatment is performed.
    Type: Grant
    Filed: February 19, 2015
    Date of Patent: August 28, 2018
    Inventors: William M. Vaughan, Gerald W. Surrett
  • Publication number: 20150238379
    Abstract: A system and method are provided for performing hyperbaric oxygen therapy treatment to stop a cascading effect of an inflammatory response to an injury. Hyperbaric oxygen therapy is performed during the inflammation to suppress the release of cytokines, most preferably, within 72 hours of sustaining the injury. Subject to evaluation of the patient, at least a second hyperbaric oxygen therapy treatment is performed.
    Type: Application
    Filed: February 19, 2015
    Publication date: August 27, 2015
    Inventors: WILLIAM M. VAUGHAN, GERALD W. SURRETT